Poor Avastin responders in AMD & DME may have increased risk to obstructive sleep apnea

Posted on January 3, 2015January 3, 2015 by admin

Poor responders to Bevacizumab (Avastin) in patients with age-related macular degeneration (AMD) and diabetic macular edema (DME) may have increased risk to obstructive sleep apnea (OSA).